体质量指数对高龄冠心病患者经皮冠状动脉介入术后远期预后的影响分析

doi:10.3969/j.issn.1671-7171.2020.12.030

Abstract
Figure/Table
References (19)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To analyze the effect of body mass index (BMI) on the long-term prognosis of elderly patients with coronary heart disease after percutaneous coronary intervention (PCI). 【Methods】From June 2014 to December 2018, 278 patients with stable coronary heart disease aged over 60 years were selected and divided into normal weight group (BMI of 18.5-24.0 kg/m²,n=81), overweight group (BMI of 24.1-28.0 kg/m²,n=134) and obesity group (BMI>28.0 kg/m²,n=63) according to BMI. The clinical data of the patients in the admitted were collected to analyze the influence of BMI on the long-term prognosis of patients. 【Results】There were no significant differences in age, diabetes mellitus, hypertension, hyperlipidemia, white blood cell (WBC), platelet (PLT), hemoglobin (HB), high density lipoprotein cholesterol (HDL-C) and total cholesterol (TC) levels among the three groups (P<0.05). The 2-year mortality and incidence of adverse events in normal weight group were 8.64% and 32.10%, which were significantly higher than those in overweight group (2.24%, 17.16%) and obesity group (1.59% and 11.11%) (P<0.05). Logistic regression analysis showed that age≥70 years, waist circumference ≥ 90 cm, diabetes mellitus, hypertension, hyperlipidemia and normal BMI were independent risk factors for adverse events after PCI in patients with stable coronary heart disease (P<0.05). 【Conclusion】Although the elderly patients with coronary heart disease with BMI ≥ 24.0 kg/m² have more risk factors than those with normal BMI, their long-term prognosis after PCI is better than those with normal BMI, and the risk of death is lower than that of patients with normal BMI.

Key words： Coronary Disease Angioplasty, Balloon, Coronary Body Mass Index Aged Prognosis Risk Factors

Received: 20 October 2020

PACS:

R541.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU Qian
	WU Qiu-ye
	ZHU Li

Cite this article:

XU Qian,WU Qiu-ye,ZHU Li. Effect of Body Mass Index on Long-term Prognosis of Elderly Patients with Coronary Heart Disease after Percutaneous Poronary Intervention[J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(12): 1859-1863.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2020.12.030 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2020/V37/I12/1859

[1] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[2] 雷新宇.高龄冠心病患者应用经皮冠状动脉介入治疗的预后及影响因素分析[J].中国药物与临床,2019,19(16):2787-2788.
[3] Jenkins DA, Bowden J, Robinson HA, et al.Adiposity-mortality relationships in type 2 diabetes, coronary heart disease, and cancer subgroups in the uk biobank, and their modification by smoking [J].Diabetes Care,2018,41(9):1878-1886.
[4] Lavie CJ, Kachur S, De Schutter A.Is there an obesity paradox in coronary heart disease in Asia [J].Coron Artery Dis,2017,28(4):273-274.
[5] Asgari S, Barzin M, Hosseinpanah F, et al.Obesity paradox and recurrent coronary heart disease in a population-based study: tehran lipid and glucose study[J].Int J Endocrinol Metab,2016,14(2):e37018.
[6] 中国肥胖问题工作组数据汇总分析协作组.我国成人体重指数和腰围对相关疾病危险因素异常的预测价值:适宜体重指数和腰围切点的研究[J].中华流行病学杂志,2002,23(1):5-10.
[7] 王欢欢,姚懿,唐晓芳,等.体重指数对冠心病行经皮冠状动脉介入治疗术后患者血小板高反应性及长期预后的影响[J].中国循环杂志,2019,34(1):32-37.
[8] 杜梦阳,姜琳,宋莹,等.不同性别≥75岁老年冠心病患者经皮冠状动脉介入治疗的预后分析[J].中国循环杂志,2019,34(1):38-43.
[9] 成万钧,周玉杰,赵迎新,等.体重对冠状动脉介入术患者氯吡格雷负荷剂量后血小板聚集率的影响[J].中国循环杂志,2010,25(1):18-21.
[10] 于亚梅,余云华,韩贺东,等.性别差异对高龄冠心病患者经皮冠状动脉介入治疗预后的影响[J].介入放射学杂志,2018,27(11):1075-1079.
[11] 孙鑫.老年高龄冠心病患者经冠状动脉介入治疗(PCI)的长期预后分析[J].中国医药指南,2018,16(21):133-134.
[12] 刘新民,董建增,刘小慧,等.体重指数对择期经皮冠状动脉介入治疗术后全因死亡率的预测意义[J].中国介入心脏病学杂志,2018,26(5):255-260.
[13] 田静,仝林虎.体重指数与高血压病、冠心病、糖尿病、脂肪性肝病因素的相关性分析[J].内蒙古医学院学报,2011,33(S1):585-587.
[14] Numasawa Y,Kohsaka S,Miyata H,et al.Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry[J].PLoS One,2015,10(4):e0124399.
[15] Romero CA,Montori VM,Somers VK,et al. Association of body weight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies[J].Lancent,2006,368 (9536):666-678.
[16] Akin I, Schneider H, Nienaber CA. Lack of "obesity paradox" in patients presenting with ST-segment elevation myocardial infarction including cardiogenic shock: a multicenter German network registry analysis[J].BMC Cardiovasc Disord,2015, 15(1): 67-75.
[17] 杨伊萍,傅慎文,胡宪清.高龄冠心病患者PCI围术期负荷剂量阿托伐他汀的疗效及安全性分析[J].心脑血管病防治,2013,13(1):19-21.
[18] 丁胜楷,黄海涛,章美华,等.急性心肌梗死患者行PCI后1年的生存状况及相关因素分析[J].心脑血管病防治,2019,19(4):315-317.
[19] 贺欣荣,郭明贤.冠心病易患因素与体重指数的相关性分析[J].陕西医学杂志,2016,45(4):410-411.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(9): 1436-1438.